SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000819050-21-000157
Filing Date
2021-10-28
Accepted
2021-10-28 17:20:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a202110424b5finalprospectu.htm 424B5 441385
2 bbilogohr2021.jpg GRAPHIC 71984
  Complete submission text file 0000819050-21-000157.txt   541719
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254037 | Film No.: 211359526
SIC: 2836 Biological Products, (No Diagnostic Substances)